chr17-7218565-T-C

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The ENST00000648172.9(DLG4):​c.94A>G​(p.Ser32Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000253 in 1,564,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00027 ( 0 hom. )

Consequence

DLG4
ENST00000648172.9 missense

Scores

2
14

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 4.10

Publications

1 publications found
Variant links:
Genes affected
DLG4 (HGNC:2903): (discs large MAGUK scaffold protein 4) This gene encodes a member of the membrane-associated guanylate kinase (MAGUK) family. It heteromultimerizes with another MAGUK protein, DLG2, and is recruited into NMDA receptor and potassium channel clusters. These two MAGUK proteins may interact at postsynaptic sites to form a multimeric scaffold for the clustering of receptors, ion channels, and associated signaling proteins. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
ACADVL (HGNC:92): (acyl-CoA dehydrogenase very long chain) The protein encoded by this gene is targeted to the inner mitochondrial membrane where it catalyzes the first step of the mitochondrial fatty acid beta-oxidation pathway. This acyl-Coenzyme A dehydrogenase is specific to long-chain and very-long-chain fatty acids. A deficiency in this gene product reduces myocardial fatty acid beta-oxidation and is associated with cardiomyopathy. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
ACADVL Gene-Disease associations (from GenCC):
  • very long chain acyl-CoA dehydrogenase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007270336).
BP6
Variant 17-7218565-T-C is Benign according to our data. Variant chr17-7218565-T-C is described in ClinVar as [Benign]. Clinvar id is 2647321.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 18 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DLG4NM_001365.5 linkc.94A>G p.Ser32Gly missense_variant Exon 2 of 22 NP_001356.1 P78352-2B7Z647B9EGL1
DLG4NM_001321074.1 linkc.94A>G p.Ser32Gly missense_variant Exon 2 of 22 NP_001308003.1 B9EGL1
DLG4NR_135527.1 linkn.1295A>G non_coding_transcript_exon_variant Exon 2 of 21
ACADVLNM_001270447.2 linkc.131+747T>C intron_variant Intron 2 of 20 NP_001257376.1 P49748-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DLG4ENST00000648172.9 linkc.94A>G p.Ser32Gly missense_variant Exon 2 of 22 ENSP00000497806.3 P78352-2
DLG4ENST00000399510.8 linkc.94A>G p.Ser32Gly missense_variant Exon 2 of 22 1 ENSP00000382428.3 B9EGL1
DLG4ENST00000491753.2 linkn.94A>G non_coding_transcript_exon_variant Exon 2 of 21 2 ENSP00000467897.2 B7Z3U2
ACADVLENST00000543245.6 linkc.131+747T>C intron_variant Intron 2 of 20 2 ENSP00000438689.2 P49748-3

Frequencies

GnomAD3 genomes
AF:
0.000118
AC:
18
AN:
152120
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00352
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000649
AC:
112
AN:
172638
AF XY:
0.000846
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000280
Gnomad OTH exome
AF:
0.000213
GnomAD4 exome
AF:
0.000268
AC:
378
AN:
1411842
Hom.:
0
Cov.:
31
AF XY:
0.000371
AC XY:
259
AN XY:
697582
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32174
American (AMR)
AF:
0.00
AC:
0
AN:
37056
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25300
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36786
South Asian (SAS)
AF:
0.00411
AC:
329
AN:
79972
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50078
Middle Eastern (MID)
AF:
0.000175
AC:
1
AN:
5714
European-Non Finnish (NFE)
AF:
0.0000249
AC:
27
AN:
1086210
Other (OTH)
AF:
0.000359
AC:
21
AN:
58552
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
29
59
88
118
147
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000118
AC:
18
AN:
152238
Hom.:
0
Cov.:
32
AF XY:
0.000175
AC XY:
13
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41530
American (AMR)
AF:
0.00
AC:
0
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00352
AC:
17
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67998
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000321
Hom.:
0
Bravo
AF:
0.0000491
ExAC
AF:
0.000382
AC:
45
Asia WGS
AF:
0.00260
AC:
9
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

DLG4-related disorder Benign:1
Feb 17, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Jan 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DLG4: PP2, BP4, BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.34
.;T
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.0022
FATHMM_MKL
Benign
0.73
D
LIST_S2
Benign
0.68
T;T
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.0073
T;T
MetaSVM
Benign
-1.0
T
PhyloP100
4.1
PROVEAN
Benign
-0.65
.;N
REVEL
Benign
0.048
Sift
Uncertain
0.0090
.;D
Sift4G
Benign
0.088
.;T
Polyphen
0.22
B;B
Vest4
0.53
MutPred
0.60
Gain of catalytic residue at S32 (P = 0.0244);Gain of catalytic residue at S32 (P = 0.0244);
MVP
0.62
MPC
1.1
ClinPred
0.046
T
GERP RS
4.5
gMVP
0.37
Mutation Taster
=97/3
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs565495109; hg19: chr17-7121884; API